Clinical Trial Update: Staggered, Chemo-Immunotherapy With Durvalumab, MEDI4736 Pemetrexed & Carboplatin (PC) for Metastatic Non-Squamous NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating staggered durvalumab with pemetrexed and carboplatin for metastatic non-squamous non-small cell lung cancer; the study is currently ACT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Durvalumab (durvalumab)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: University of Utah | Conditions: Non-Small Cell Lung Cancer Metastatic | Phase 2 | Status: ACTIVE_NOT_RECRUITING